Treatment with Rituximab in the Acute Phase of Relapsing Remitting Multiple Sclerosis

There have been a few reports on the administration of rituximab for relapsing-remitting multiple sclerosis (RRMS) in the acute phase. We report the case of a 62-year-old woman with an acute lesion of RRMS. Although corticosteroid therapy and plasmapheresis were not effective, the lesion improved wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shima, Ayano, Hamaguchi, Tsuyoshi, Tada, Yasutake, Yamada, Masahito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995712/
https://www.ncbi.nlm.nih.gov/pubmed/31462595
http://dx.doi.org/10.2169/internalmedicine.3408-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995712/
https://www.ncbi.nlm.nih.gov/pubmed/31462595
http://dx.doi.org/10.2169/internalmedicine.3408-19

Ejemplares similares